# FDA Inspection 951773 - Marshallton Capital Group - November 23, 2015

Source: https://www.keypedia.com/records/fda_inspections/marshallton-capital-group/ee22e70a-c944-42ae-8ce1-d554abee9caa
Source feed: FDA_Inspections

> FDA Inspection 951773 for Marshallton Capital Group on November 23, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 951773
- Company Name: Marshallton Capital Group
- Inspection Date: 2015-11-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1086716 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/marshallton-capital-group/afa582ed-4f68-45da-ab65-91bd418d5c03)
- [FDA Inspection 736657 - 2011-07-05](https://www.keypedia.com/records/fda_inspections/marshallton-capital-group/b19f039b-9ff7-4144-8969-1570d46fed1d)

Company: https://www.keypedia.com/companies/marshallton-capital-group/c014aa6a-4996-4cee-85d6-418d82476179

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d